Electronic cigarettes: A task force report from the European Respiratory Society

European Respiratory Journal

Volumn 53, Issue 2, 2019, Pages

  Bals, Robert ^k   Boyd, Jeanette ^a   Esposito, Susanna ^b   Foronjy, Robert ^c   Hiemstra, Pieter S ^d   Jiménez Ruiz, Carlos A ^e   Katsaounou, Paraskevi ^f   Lindberg, Anne ^g   Metz, Carlos ^k   Schober, Wolfgang ^h   Spira, Avrum ⁱ   Blasi, Francesco ^j  

^a European Lung Foundation   (United Kingdom)

^b UNIVERSITY OF PERUGIA   (Italy)

^c SUNY DOWNSTATE MEDICAL CENTER   (United States)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e Smoking Cessation Service   (Spain)

^f UNIVERSITY OF ATHENS   (Greece)

^g UMEÅ UNIVERSITY   (Sweden)

^h Bavarian Health and Food Safety Authority   (Germany)

ⁱ BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j UNIVERSITY OF MILAN   (Italy)

^k SAARLAND UNIVERSITY   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; LACTATE DEHYDROGENASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINE; PROPYLENE GLYCOL;

AEROSOL; AIRWAY EPITHELIUM CELL; CAENORHABDITIS ELEGANS; CALORIC INTAKE; CANCER PATIENT; CASE STUDY; CYTOKINE RELEASE; CYTOTOXICITY; ENZYME ACTIVITY; FOOD INTAKE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; METABOLOMICS; NONHUMAN; OXIDATIVE STRESS; POPULATION RESEARCH; PRIORITY JOURNAL; RESPIRATORY TRACT ALLERGY; REVIEW; SMOKING; SMOKING CESSATION; SPERMATOZOON DENSITY; STREPTOCOCCUS PNEUMONIAE; SYSTEMATIC REVIEW; TRANSCRIPTOMICS; UNITED STATES; ZEBRA FISH; ADOLESCENT; ADULT; ANIMAL; C57BL MOUSE; DRUG EFFECT; ELECTRONIC CIGARETTE; EPIDEMIOLOGY; EPITHELIUM CELL; EUROPE; MOUSE; ORGANIZATION AND MANAGEMENT; PASSIVE SMOKING; PROCEDURES; PULMONOLOGY; RAT; TOBACCO; TOBACCO DEPENDENCE; VAPING; YOUNG ADULT;

ADOLESCENT; ADULT; ANIMALS; CAENORHABDITIS ELEGANS; ELECTRONIC NICOTINE DELIVERY SYSTEMS; EPITHELIAL CELLS; EUROPE; HUMANS; IN VITRO TECHNIQUES; MICE; MICE, INBRED C57BL; PULMONARY MEDICINE; RATS; SMOKING CESSATION; TOBACCO PRODUCTS; TOBACCO SMOKE POLLUTION; TOBACCO USE DISORDER; VAPING; YOUNG ADULT; ZEBRAFISH;

EID: 85061444585     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/13993003.01151-2018     Document Type: Review

References (291)

1. Zyoud S, Al-Jabi SW, Sweileh WM. Worldwide research productivity in the field of electronic cigarette: a bibliometric analysis. BMC Public Health 2014; 14: 667.
2. Schraufnagel DE, Blasi F, Drummond MB, et al. Electronic cigarettes. A position statement of the forum of international respiratory societies. Am J Respir Crit Care Med 2014; 190: 611–618.
3. Camenga DR, Delmerico J, Kong G, et al. Trends in use of electronic nicotine delivery systems by adolescents. Addict Behav 2014; 39: 338–340.
4. Cho JH, Shin E, Moon S-S. Electronic-cigarette smoking experience among adolescents. J Adolesc Health 2011; 49: 542–546.
5. Barnett TE, Soule EK, Forrest JR, et al. Adolescent electronic cigarette use: associations with conventional cigarette and hookah smoking. Am J Prev Med 2015; 49: 199–206.
6. Kasza KA, Ambrose BK, Conway KP, et al. Tobacco-product use by adults and youths in the United States in 2013 and 2014. N Engl J Med 2017; 376: 342–353.
7. White J, Li J, Newcombe R, et al. Tripling use of electronic cigarettes among New Zealand adolescents between 2012 and 2014. J Adolesc Health 2015; 56: 522–528.
8. Caraballo RS, Jamal A, Nguyen KH, et al. Electronic nicotine delivery system use among U.S. adults, 2014. Am J Prev Med 2016; 50: 226–229.
9. Czoli CD, Hammond D, Reid JL, et al. Use of conventional and alternative tobacco and nicotine products among a sample of Canadian youth. J Adolesc Health 2015; 57: 123–125.
10. Dutra LM, Glantz SA. Electronic cigarettes and conventional cigarette use among U.S. adolescents: a cross-sectional study. JAMA Pediatr 2014; 168: 610–617.
11. Eastwood B, Dockrell MJ, Arnott D, et al. Electronic cigarette use in young people in Great Britain 2013–2014. Public Health 2015; 129: 1150–1156.
12. Gilreath TD, Leventhal A, Barrington-Trimis JL, et al. Patterns of alternative tobacco product use: emergence of hookah and e-cigarettes as preferred products amongst youth. J Adolesc Health 2016; 58: 181–185.
13. Krishnan-Sarin S, Morean ME, Camenga DR, et al. E-cigarette use among high school and middle school adolescents in Connecticut. Nicotine Tob Res 2015; 17: 810–818.
14. Lee YO, Hebert CJ, Nonnemaker JM, et al. Youth tobacco product use in the United States. Pediatrics 2015; 135: 409–415.
15. Corsi DJ, Lippert AM. An examination of the shift in school-level clustering of US adolescent electronic cigarette use and its multilevel correlates, 2011–2013. Health Place 2016; 38: 30–38.
16. Warner KE. Frequency of e-cigarette use and cigarette smoking by American students in 2014. Am J Prev Med 2016; 51: 179–184.
17. Cardenas VM, Breen PJ, Compadre CM, et al. The smoking habits of the family influence the uptake of e-cigarettes in US children. Ann Epidemiol 2015; 25: 60–62.
18. Hanewinkel R, Isensee B. Risk factors for e-cigarette, conventional cigarette, and dual use in German adolescents: a cohort study. Prev Med 2015; 74: 59–62.
19. Bauld L, MacKintosh AM, Ford A, et al. E-cigarette uptake amongst UK youth: experimentation, but little or no regular use in nonsmokers. Nicotine Tob Res 2016; 18: 102–103.
20. Ooms GI, Bosdriesz JR, Portrait FR, et al. Sociodemographic differences in the use of electronic nicotine delivery systems in the European Union. Nicotine Tob Res 2016; 18: 724–729.
21. Vardavas CI, Filippidis FT, Agaku IT. Determinants and prevalence of e-cigarette use throughout the European Union: a secondary analysis of 26 566 youth and adults from 27 countries. Tob Control 2015; 24: 442–448.
22. Agaku IT, Filippidis FT, Vardavas CI, et al. Poly-tobacco use among adults in 44 countries during 2008-2012: evidence for an integrative and comprehensive approach in tobacco control. Drug Alcohol Depend 2014; 139: 60–70.
23. European Commission. Special Eurobarometer 458: Attitudes of Europeans Towards Tobacco and Electronic Cigarettes. 2017. https://data.europa.eu/euodp/en/data/dataset/S2146_87_1_458_ENG Date last updated: May 25, 2018.
24. Tavolacci MP, Vasiliu A, Romo L, et al. Patterns of electronic cigarette use in current and ever users among college students in France: a cross-sectional study. BMJ Open 2016; 6: e011344.
25. Gravely S, Fong GT, Cummings KM, et al. Awareness, trial, and current use of electronic cigarettes in 10 countries: findings from the ITC project. Int J Environ Res Public Health 2014; 11: 11691–11704.
26. Andler R, Guignard R, Wilquin JL, et al. Electronic cigarette use in France in 2014. Int J Public Health 2016; 61: 159–165.
27. Babineau K, Taylor K, Clancy L. Electronic cigarette use among Irish youth: a cross sectional study of prevalence and associated factors. PLoS One 2015; 10: e0126419.
28. Adkison SE, O’Connor RJ, Bansal-Travers M, et al. Electronic nicotine delivery systems: international tobacco control four-country survey. Am J Prev Med 2013; 44: 207–215.
29. Allem J-P, Forster M, Neiberger A, et al. Characteristics of emerging adulthood and e-cigarette use: findings from a pilot study. Addict Behav 2015; 50: 40–44.
30. Brown J, West R, Beard E, et al. Prevalence and characteristics of e-cigarette users in Great Britain: findings from a general population survey of smokers. Addict Behav 2014; 39: 1120–1125.
31. Dockrell M, Morrison R, Bauld L, et al. E-cigarettes: prevalence and attitudes in Great Britain. Nicotine Tob Res 2013; 15: 1737–1744.
32. Douptcheva N, Gmel G, Studer J, et al. Use of electronic cigarettes among young Swiss men. J Epidemiol Community Health 2013; 67: 1075–1076.
33. King BA, Patel R, Nguyen KH, et al. Trends in awareness and use of electronic cigarettes among US adults, 2010-2013. 2015; 17: 219–227.
34. McMillen RC, Gottlieb MA, Shaefer RMW, et al. Trends in electronic cigarette use among U.S. adults: use is increasing in both smokers and nonsmokers. Nicotine Tob Res 2015; 17: 1195–1202.
35. Weaver SR, Majeed BA, Pechacek TF, et al. Use of electronic nicotine delivery systems and other tobacco products among USA adults, 2014: results from a national survey. Int J Public Health 2016; 61: 177–188.
36. Rutten LJF, Blake KD, Agunwamba AA, et al. Use of e-cigarettes among current smokers: associations among reasons for use, quit intentions, and current tobacco use. Nicotine Tob Res 2015; 17: 1228–1234.
37. Adkison SE, O’Connor RJ, Bansal-Travers M, et al. Electronic nicotine delivery systems: international tobacco control four-country survey. Am J Prev Med 2013; 44: 207–215.
38. Borderud SP, Li Y, Burkhalter JE, et al. Electronic cigarette use among patients with cancer: characteristics of electronic cigarette users and their smoking cessation outcomes. Cancer 2014; 120: 3527–3535.
39. Farsalinos KE, Poulas K, Voudris V, et al. Electronic cigarette use in the European Union: analysis of a representative sample of 27460 Europeans from 28 countries. Addiction 2016; 111: 2032–2040.
40. Filippidis FT, Gerovasili V, Laverty AA. Commentary on Farsalinos et al. (2016): Electronic cigarette use in the European Union: analysis of a representative sample of 27460 Europeans from 28 countries. Addiction 2017; 112: 544–545.
41. Laverty AA, Vardavas CI, Filippidis FT. Design and marketing features influencing choice of e-cigarettes and tobacco in the EU. Eur J Public Health 2016; 26: 838–841.
42. Pepper JK, Ribisl KM, Emery SL, et al. Reasons for starting and stopping electronic cigarette use. Int J Environ Res Public Health 2014; 11: 10345–10361.
43. Kong G, Morean ME, Cavallo DA, et al. Reasons for electronic cigarette experimentation and discontinuation among adolescents and young adults. Nicotine Tob Res 2015; 17: 847–854.
44. Cummins SE, Zhu SH, Tedeschi GJ, et al. Use of e-cigarettes by individuals with mental health conditions. Tob Control 2014; 23: Suppl. 3, iii48–iii53.
45. Prochaska JJ, Grana RA. E-cigarette use among smokers with serious mental illness. PLoS One 2014; 9: e113013.
46. Lee YO, Hebert CJ, Nonnemaker JM, et al. Multiple tobacco product use among adults in the United States: cigarettes, cigars, electronic cigarettes, hookah, smokeless tobacco, and snus. Prev Med 2014; 62: 14–19.
47. Amato MS, Boyle RG, Levy D. How to define e-cigarette prevalence? Finding clues in the use frequency distribution. Tob Control 2016; 25: e24–e29.
48. Giovenco DP, Lewis MJ, Delnevo CD. Factors associated with e-cigarette use: a national population survey of current and former smokers. Am J Prev Med 2014; 47: 476–480.
49. Lerner CA, Sundar IK, Yao H, et al. Vapors produced by electronic cigarettes and e-juices with flavorings induce toxicity, oxidative stress, and inflammatory response in lung epithelial cells and in mouse lung. PLoS One 2015; 10: e0116732.
50. Hiemstra PS, Bals R. Basic science of electronic cigarettes: assessment in cell culture and in vivo models. Respir Res 2016; 17: 127.
51. Schweitzer KS, Chen SX, Law S, et al. Endothelial disruptive proinflammatory effects of nicotine and e-cigarette vapor exposures. Am J Physiol Lung Cell Mol Physiol 2015; 309: L175–L187.
52. Farsalinos KE, Romagna G, Allifranchini E, et al. Comparison of the cytotoxic potential of cigarette smoke and electronic cigarette vapour extract on cultured myocardial cells. Int J Environ Res Public Health 2013; 10: 5146–5162.
53. Romagna G, Allifranchini E, Bocchietto E, et al. Cytotoxicity evaluation of electronic cigarette vapor extract on cultured mammalian fibroblasts (ClearStream-LIFE): comparison with tobacco cigarette smoke extract. Inhal Toxicol 2013; 25: 354–361.
54. Moses E, Wang T, Corbett S, et al. Molecular impact of electronic cigarette aerosol exposure in human bronchial epithelium. Toxicol Sci 2017; 155: 248–257.
55. Misra M, Leverette RD, Cooper BT, et al. Comparative in vitro toxicity profile of electronic and tobacco cigarettes, smokeless tobacco and nicotine replacement therapy products: e-liquids, extracts and collected aerosols. Int J Environ Res Public Health 2014; 11: 11325–11347.
56. Scheffler S, Dieken H, Krischenowski O, et al. Evaluation of E-cigarette liquid vapor and mainstream cigarette smoke after direct exposure of primary human bronchial epithelial cells. Int J Environ Res Public Health 2015; 12: 3915–3925.
57. Cervellati F, Muresan XM, Sticozzi C, et al. Comparative effects between electronic and cigarette smoke in human keratinocytes and epithelial lung cells. Toxicol In Vitro 2014; 28: 999–1005.
58. Husari A, Shihadeh A, Talih S, et al. Acute exposure to electronic and combustible cigarette aerosols: effects in an animal model and in human alveolar cells. Nicotine Tob Res 2016; 18: 613–619.
59. Aug A, Altraja S, Kilk K, et al. E-cigarette affects the metabolome of primary normal human bronchial epithelial cells. PLoS One 2015; 10: e0142053.
60. Neilson L, Mankus C, Thorne D, et al. Development of an in vitro cytotoxicity model for aerosol exposure using 3D reconstructed human airway tissue; application for assessment of e-cigarette aerosol. Toxicol In Vitro 2015; 29: 1952–1962.
61. Shivalingappa PC, Hole R, Westphal CV, et al. Airway exposure to e-cigarette vapors impairs autophagy and induces aggresome formation. Antioxid Redox Signal 2015; 24: doi: 10.1089/ars.2015.6367.
62. Sancilio S, Gallorini M, Cataldi A, et al. Cytotoxicity and apoptosis induction by e-cigarette fluids in human gingival fibroblasts. Clin Oral Investig 2016; 20: 477–483.
63. Yoshiyama S, Chen Z, Okagaki T, et al. Nicotine exposure alters human vascular smooth muscle cell phenotype from a contractile to a synthetic type. Atherosclerosis 2014; 237: 464–470.
64. Bahl V, Lin S, Xu N, et al. Comparison of electronic cigarette refill fluid cytotoxicity using embryonic and adult models. Reprod Toxicol 2012; 34: 529–537.
65. Higham A, Rattray NJ, Dewhurst JA, et al. Electronic cigarette exposure triggers neutrophil inflammatory responses. Respir Res 2016; 17: 56.
66. Rubenstein DA, Hom S, Ghebrehiwet B, et al. Tobacco and e-cigarette products initiate Kupffer cell inflammatory responses. Mol Immunol 2015; 67: 652–660.
67. Wu Q, Jiang D, Minor M, et al. Electronic cigarette liquid increases inflammation and virus infection in primary human airway epithelial cells. PLoS One 2014; 9: e108342.
68. Kosmider L, Sobczak A, Fik M, et al. Carbonyl compounds in electronic cigarette vapors: effects of nicotine solvent and battery output voltage. Nicotine Tob Res 2014; 16: 1319–1326.
69. Yu V, Rahimy M, Korrapati A, et al. Electronic cigarettes induce DNA strand breaks and cell death independently of nicotine in cell lines. Oral Oncol 2016; 52: 58–65.
70. Lim HB, Kim SH. Inhallation of e-cigarette cartridge solution aggravates allergen-induced airway inflammation and hyper-responsiveness in mice. Toxicol Res 2014; 30: 13–18.
71. Garcia-Arcos I, Geraghty P, Baumlin N, et al. Chronic electronic cigarette exposure in mice induces features of COPD in a nicotine-dependent manner. Thorax 2016; 71: 1119–1129.
72. Phillips B, Veljkovic E, Peck MJ, et al. A 7-month cigarette smoke inhalation study in C57BL/6 mice demonstrates reduced lung inflammation and emphysema following smoking cessation or aerosol exposure from a prototypic modified risk tobacco product. Food Chem Toxicol 2015; 80: 328–345.
73. Sussan TE, Gajghate S, Thimmulappa RK, et al. Exposure to electronic cigarettes impairs pulmonary anti-bacterial and anti-viral defenses in a mouse model. PLoS One 2015; 10: e0116861.
74. Hwang JH, Lyes M, Sladewski K, et al. Electronic cigarette inhalation alters innate immunity and airway cytokines while increasing the virulence of colonizing bacteria. J Mol Med 2016; 94: 667–679.
75. Canistro D, Vivarelli F, Cirillo S, et al. E-cigarettes induce toxicological effects that can raise the cancer risk. Sci Rep 2017; 7: 2028.
76. McGrath-Morrow SA, Hayashi M, Aherrera A, et al. The effects of electronic cigarette emissions on systemic cotinine levels, weight and postnatal lung growth in neonatal mice. PLoS One 2015; 10: e0118344.
77. Ponzoni L, Moretti M, Sala M, et al. Different physiological and behavioural effects of e-cigarette vapour and cigarette smoke in mice. Eur Neuropsychopharmacol 2015; 25: 1775–1786.
78. Smith D, Aherrera A, Lopez A, et al. Adult behavior in male mice exposed to e-cigarette nicotine vapors during late prenatal and early postnatal life. PLoS One 2015; 10: e0137953.
79. Golli NE, Rahali D, Jrad-Lamine A, et al. Impact of electronic-cigarette refill liquid on rat testis. Toxicol Mech Methods 2016; 26: 427–434.
80. Golli NE, Dkhili H, Dallagi Y, et al. Comparison between electronic cigarette refill liquid and nicotine on metabolic parameters in rats. Life Sci 2016; 146: 131–138.
81. Golli NE, Jrad-Lamine A, Neffati H, et al. Impact of e-cigarette refill liquid exposure on rat kidney. Regul Toxicol Pharmacol 2016; 77: 109–116.
82. Palpant NJ, Hofsteen P, Pabon L, et al. Cardiac development in zebrafish and human embryonic stem cells is inhibited by exposure to tobacco cigarettes and e-cigarettes. PLoS One 2015; 10: e0126259.
83. Panitz D, Swamy H, Nehrke K. A C. elegans model of electronic cigarette use: physiological effects of e-liquids in nematodes. BMC Pharmacol Toxicol 2015; 16: 32.
84. Brown JE, Luo W, Isabelle LM, et al. Candy flavorings in tobacco. N Engl J Med 2014; 370: 2250–2252.
85. Lisko JG, Tran H, Stanfill SB, et al. Chemical composition and evaluation of nicotine, tobacco alkaloids, pH, and selected flavors in e-cigarette cartridges and refill solutions. Nicotine Tob Res 2015; 17: 1270–1278.
86. Peace MR, Baird TR, Smith N, et al. Concentration of nicotine and glycols in 27 electronic cigarette formulations. J Anal Toxicol 2016; 40: 403–407.
87. Barrington-Trimis JL, Samet JM, McConnell R. Flavorings in electronic cigarettes: an unrecognized respiratory health hazard? JAMA 2014; 312: 2493–2494.
88. Behar RZ, Davis B, Wang Y, et al. Identification of toxicants in cinnamon-flavored electronic cigarette refill fluids. Toxicol In Vitro 2014; 28: 198–208.
89. Kosmider L, Sobczak A, Prokopowicz A, et al. Cherry-flavoured electronic cigarettes expose users to the inhalation irritant, benzaldehyde. Thorax 2016; 71: 376–377.
90. Farsalinos KE, Kistler KA, Gillman G, et al. Evaluation of electronic cigarette liquids and aerosol for the presence of selected inhalation toxins. Nicotine Tob Res 2015; 17: 168–174.
91. El-Hellani A, El-Hage R, Baalbaki R, et al. Free-base and protonated nicotine in electronic cigarette liquids and aerosols. Chem Res Toxicol 2015; 28: 1532–1537.
92. Jensen RP, Luo W, Pankow JF, et al. Hidden formaldehyde in e-cigarette aerosols. N Engl J Med 2015; 372: 392–394.
93. Sleiman M, Logue JM, Montesinos VN, et al. Emissions from electronic cigarettes: key parameters affecting the release of harmful chemicals. Environ Sci Technol 2016; 50: 9644–9651.
94. Uchiyama S, Ohta K, Inaba Y, et al. Determination of carbonyl compounds generated from the e-cigarette using coupled silica cartridges impregnated with hydroquinone and 2,4-dinitrophenylhydrazine, followed by high-performance liquid chromatography. Anal Sci 2013; 29: 1219–1222.
95. Pankow JF, Kim K, McWhirter KJ, et al. Benzene formation in electronic cigarettes. PLoS One 2017; 12: e0173055.
96. Khlystov A, Samburova V. Flavoring compounds dominate toxic aldehyde production during e-cigarette vaping. Environ Sci Technol 2016; 50: 13080–13085.
97. Goniewicz ML, Knysak J, Gawron M, et al. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control 2014; 23: 133–139.
98. Mikheev VB, Brinkman MC, Granville CA, et al. Real-time measurement of electronic cigarette aerosol size distribution and metals content analysis. Nicotine Tob Res 2016; 18: 1895–1902.
99. Goel R, Durand E, Trushin N, et al. Highly reactive free radicals in electronic cigarette aerosols. Chem Res Toxicol 2015; 28: 1675–1677.
100. Vardavas CI, Anagnostopoulos N, Kougias M, et al. Short-term pulmonary effects of using an electronic cigarette: impact on respiratory flow resistance, impedance, and exhaled nitric oxide. Chest 2012; 141: 1400–1406.
101. Palamidas A, Tsikrika S, Katsaounou P, et al. Acute effects of short term use of e-cigarettes on airways physiology and respiratory symptoms in smokers with and without airways obstructive diseases and in healthy non smokers. Tob Prev Cessation 2017; 3: 5.
102. Flouris AD, Chorti MS, Poulianiti KP, et al. Acute impact of active and passive electronic cigarette smoking on serum cotinine and lung function. Inhal Toxicol 2013; 25: 91–101.
103. Cibella F, Campagna D, Caponnetto P, et al. Lung function and respiratory symptoms in a randomized smoking cessation trial of electronic cigarettes. Clin Sci 2016; 130: 1929–1937.
104. Polosa R, Morjaria JB, Caponnetto P, et al. Evidence for harm reduction in COPD smokers who switch to electronic cigarettes. Respir Res 2016; 17: 166.
105. Vansickel AR, Cobb CO, Weaver MF, et al. A clinical laboratory model for evaluating the acute effects of electronic “cigarettes”: nicotine delivery profile and cardiovascular and subjective effects. Cancer Epidemiol Biomarkers Prev 2010; 19: 1945–1953.
106. Vansickel AR, Eissenberg T. Electronic cigarettes: effective nicotine delivery after acute administration. Nicotine Tob Res 2013; 15: 267–270.
107. Farsalinos KE, Tsiapras D, Kyrzopoulos S, et al. Acute effects of using an electronic nicotine-delivery device (electronic cigarette) on myocardial function: comparison with the effects of regular cigarettes. BMC Cardiovasc Disord 2014; 14: 78.
108. Polosa R, Morjaria JB, Caponnetto P, et al. Blood pressure control in smokers with arterial hypertension who switched to electronic cigarettes. Int J Environ Res Public Health 2016; 13: E1123.
109. Farsalinos K, Cibella F, Caponnetto P, et al. Effect of continuous smoking reduction and abstinence on blood pressure and heart rate in smokers switching to electronic cigarettes. Intern Emerg Med 2016: 85–94.
110. Vlachopoulos C, Ioakeimidis N, Abdelrasoul M, et al. Electronic cigarette smoking increases aortic stiffness and blood pressure in young smokers. J Am Coll Cardiol 2016; 67: 2802–2803.
111. Szołtysek-Bołdys I, Sobczak A, Zielińska-Danch W, et al. Influence of inhaled nicotine source on arterial stiffness. Przegl Lek 2014; 71: 572–575.
112. Carnevale R, Sciarretta S, Violi F, et al. Acute impact of tobacco vs electronic cigarette smoking on oxidative stress and vascular function. Chest 2016; 150: 606–612.
113. Antoniewicz L, Bosson JA, Kuhl J, et al. Electronic cigarettes increase endothelial progenitor cells in the blood of healthy volunteers. Atherosclerosis 2016; 255: 179–185.
114. Moheimani RS, Bhetraratana M, Yin F, et al. Increased cardiac sympathetic activity and oxidative stress in habitual electronic cigarette users: implications for cardiovascular risk. JAMA Cardiol 2017; 2: 278–284.
115. Miech RA, O’Malley PM, Johnston LD, et al. E-cigarettes and the drug use patterns of adolescents. Nicotine Tob Res 2016; 18: 654–659.
116. Laugesen M. Nicotine and toxicant yield ratings of electronic cigarette brands in New Zealand. NZ Med J 2015; 128: 77–82.
117. Filippini P, Cesario A, Fini M, et al. The yin and yang of non-neuronal α7-nicotinic receptors in inflammation and autoimmunity. Curr Drug Targets 2012; 13: 644–655.
118. 2+ in rat airway smooth muscle cells via activating and up-regulating α7-nicotinic acetylcholine receptor. Cell Physiol Biochem 2014; 33: 389–401.
119. Wilk JB, Shrine NR, Loehr LR, et al. Genome-wide association studies identify CHRNA5/3 and HTR4 in the development of airflow obstruction. Am J Respir Crit Care Med 2012; 186: 622–632.
120. Zia S, Ndoye A, Nguyen VT, et al. Nicotine enhances expression of the alpha 3, alpha 4, alpha 5, and alpha 7 nicotinic receptors modulating calcium metabolism and regulating adhesion and motility of respiratory epithelial cells. Res Commun Mol Pathol Pharmacol 1997; 97: 243–262.
121. Maus AD, Pereira EF, Karachunski PI, et al. Human and rodent bronchial epithelial cells express functional nicotinic acetylcholine receptors. Mol Pharmacol 1998; 54: 779–788.
122. Carlisle DL, Hopkins TM, Gaither-Davis A, et al. Nicotine signals through muscle-type and neuronal nicotinic acetylcholine receptors in both human bronchial epithelial cells and airway fibroblasts. Respir Res 2004; 5: 27.
123. Maouche K, Polette M, Jolly T, et al. α7 nicotinic acetylcholine receptor regulates airway epithelium differentiation by controlling basal cell proliferation. Am J Pathol 2009; 175: 1868–1882.
124. Proskocil BJ, Sekhon HS, Jia Y, et al. Acetylcholine is an autocrine or paracrine hormone synthesized and secreted by airway bronchial epithelial cells. Endocrinology 2004; 145: 2498–2506.
125. Li ZZ, Dai QY. Pathogenesis of abdominal aortic aneurysms: role of nicotine and nicotinic acetylcholine receptors. Mediators Inflamm 2012; 2012: 103120.
126. Fu XW, Wood K, Spindel ER. Prenatal nicotine exposure increases GABA signaling and mucin expression in airway epithelium. Am J Respir Cell Mol Biol 2011; 44: 222–229.
127. Hahn HL, Lang M, Bleicher S, et al. Nicotine-induced airway smooth muscle contraction: neural mechanisms involving the airway epithelium. Functional and histologic studies in vitro. Clin Investig 1992; 70: 252–262.
128. Takayanagi I, Kizawa Y, Sone H. Action of nicotine on guinea-pig isolated bronchial smooth muscle preparation. Gen Pharmacol 1984; 15: 349–352.
129. Boucherat O, Boczkowski J, Jeannotte L, et al. Cellular and molecular mechanisms of goblet cell metaplasia in the respiratory airways. Exp Lung Res 2013; 39: 207–216.
130. Barnes PJ. Cellular and molecular mechanisms of chronic obstructive pulmonary disease. Clin Chest Med 2014; 35: 71–86.
131. Maouche K, Medjber K, Zahm JM, et al. Contribution of α7 nicotinic receptor to airway epithelium dysfunction under nicotine exposure. Proc Natl Acad Sci USA 2013; 110: 4099–4104.
132. Medjber K, Freidja ML, Grelet S, et al. Role of nicotinic acetylcholine receptors in cell proliferation and tumour invasion in broncho-pulmonary carcinomas. Lung Cancer 2015; 87: 258–264.
133. Séguéla P, Wadiche J, Dineley-Miller K, et al. Molecular cloning, functional properties, and distribution of rat brain alpha 7: a nicotinic cation channel highly permeable to calcium. J Neurosci 1993; 13: 596–604.
134. Boncoeur E, Bouvet GF, Migneault F, et al. Induction of nitric oxide synthase expression by lipopolysaccharide is mediated by calcium-dependent PKCα-β1 in alveolar epithelial cells. Am J Physiol Lung Cell Mol Physiol 2013; 305: L175–L184.
135. He F, Li B, Zhao Z, et al. The pro-proliferative effects of nicotine and its underlying mechanism on rat airway smooth muscle cells. PLoS One 2014; 9: e93508.
136. Pera T, Gosens R, Lesterhuis AH, et al. Cigarette smoke and lipopolysaccharide induce a proliferative airway smooth muscle phenotype. Respir Res 2010; 11: 48.
137. Grozio A, Catassi A, Cavalieri Z, et al. Nicotine, lung and cancer. Anticancer Agents Med Chem 2007; 7: 461–466.
138. Diamond L, Kimmel EC, Lai YL, et al. Augmentation of elastase-induced emphysema by cigarette smoke. Effects of reduced nicotine content. Am Rev Respir Dis 1988; 138: 1201–1206.
139. Bodas M, Van Westphal C, Carpenter-Thompson R, et al. Nicotine exposure induces bronchial epithelial cell apoptosis and senescence via ROS mediated autophagy-impairment. Free Radic Biol Med 2016; 97: 441–453.
140. Segura-Valdez L, Pardo A, Gaxiola M, et al. Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPD. Chest 2000; 117: 684–694.
141. Geraghty P, Hardigan A, Foronjy RF. Cigarette smoke activates the proto-oncogene c-src to promote airway inflammation and lung tissue destruction. Am J Respir Cell Mol Biol 2014; 50: 559–570.
142. Iskandar AR, Liu C, Smith DE, et al. β-cryptoxanthin restores nicotine-reduced lung SIRT1 to normal levels and inhibits nicotine-promoted lung tumorigenesis and emphysema in A/J mice. Cancer Prev Res 2013; 6: 309–320.
143. Nishioka T, Guo J, Yamamoto D, et al. Nicotine, through upregulating pro-survival signaling, cooperates with NNK to promote transformation. J Cell Biochem 2010; 109: 152–161.
144. Hanaki T, Horikoshi Y, Nakaso K, et al. Nicotine enhances the malignant potential of human pancreatic cancer cells via activation of atypical protein kinase C. Biochim Biophys Acta 2016; 1860: 2404–2415.
145. Czyżykowski R, Połowinczak-Przybyłek J, Potemski P. Nicotine-induced resistance of non-small cell lung cancer to treatment – possible mechanisms. Postepy Hig Med Dosw 2016; 70: 186–193.
146. Hao J, Shi FD, Abdelwahab M, et al. Nicotinic receptor β2 determines NK cell-dependent metastasis in a murine model of metastatic lung cancer. PLoS One 2013; 8: e57495.
147. Murphy SE, von Weymarn LB, Schutten MM, et al. Chronic nicotine consumption does not influence 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis. Cancer Prev Res 2011; 4: 1752–1760.
148. Maier CR, Hollander MC, Hobbs EA, et al. Nicotine does not enhance tumorigenesis in mutant K-ras-driven mouse models of lung cancer. Cancer Prev Res 2011; 4: 1743–1751.
149. Foulds J, Ramstrom L, Burke M, et al. Effect of smokeless tobacco (snus) on smoking and public health in Sweden. Tob Control 2003; 12: 349–359.
150. Luo J, Ye W, Zendehdel K, et al. Oral use of Swedish moist snuff (snus) and risk for cancer of the mouth, lung, and pancreas in male construction workers: a retrospective cohort study. Lancet 2007; 369: 2015–2020.
151. Wilson KM, Markt SC, Fang F, et al. Snus use, smoking and survival among prostate cancer patients. Int J Cancer 2016; 139: 2753–2759.
152. Farsalinos KE, Spyrou A, Tsimopoulou K, et al. Nicotine absorption from electronic cigarette use: comparison between first and new-generation devices. Sci Rep 2014; 4: 4133.
153. Hajek P, Przulj D, Phillips A, et al. Nicotine delivery to users from cigarettes and from different types of e-cigarettes. Psychopharmacology 2017; 234: 773–779.
154. Talih S, Balhas Z, Eissenberg T, et al. Effects of user puff topography, device voltage, and liquid nicotine concentration on electronic cigarette nicotine yield: measurements and model predictions. Nicotine Tob Res 2015; 17: 150–157.
155. Wagener TL, Floyd EL, Stepanov I, et al. Have combustible cigarettes met their match? The nicotine delivery profiles and harmful constituent exposures of second-generation and third-generation electronic cigarette users. Tob Control 2017; 26: e23–e28.
156. Etter J-F. Levels of saliva cotinine in electronic cigarette users. Addiction 2014; 109: 825–829.
157. Benowitz NL, Burbank AD. Cardiovascular toxicity of nicotine: implications for electronic cigarette use. Trends Cardiovasc Med 2016; 26: 515–523.
158. Arefalk G, Hambraeus K, Lind L, et al. Discontinuation of smokeless tobacco and mortality risk after myocardial infarction. Circulation 2014; 130: 325–332.
159. Hansson J, Galanti MR, Hergens MP, et al. Use of snus and acute myocardial infarction: pooled analysis of eight prospective observational studies. Eur J Epidemiol 2012; 27: 771–779.
160. Joseph AM, Norman SM, Ferry LH, et al. The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. N Engl J Med 1996; 335: 1792–1798.
161. Meine TJ, Patel MR, Washam JB, et al. Safety and effectiveness of transdermal nicotine patch in smokers admitted with acute coronary syndromes. Am J Cardiol 2005; 95: 976–978.
162. Mills EJ, Thorlund K, Eapen S, et al. Cardiovascular events associated with smoking cessation pharmacotherapies: a network meta-analysis. Circulation 2014; 129: 28–41.
163. Wallenfeldt K, Hulthe J, Bokemark L, et al. Carotid and femoral atherosclerosis, cardiovascular risk factors and C-reactive protein in relation to smokeless tobacco use or smoking in 58-year-old men. J Intern Med 2001; 250: 492–501.
164. England LJ, Aagaard K, Bloch M, et al. Developmental toxicity of nicotine: a transdisciplinary synthesis and implications for emerging tobacco products. Neurosci Biobehav Rev 2017; 72: 176–189.
165. Rau AS, Reinikovaite V, Schmidt EP, et al. Electronic cigarettes are as toxic to skin flap survival as tobacco cigarettes. Ann Plast Surg 2017; 79: 86–91.
166. Callahan-Lyon P. Electronic cigarettes: human health effects. Tob Control 2014; 23: Suppl. 2, ii36–ii40.
167. Montharu J, Le Guellec S, Kittel B, et al. Evaluation of lung tolerance of ethanol, propylene glycol, and sorbitan monooleate as solvents in medical aerosols. J Aerosol Med Pulm Drug Deliv 2010; 23: 41–46.
168. Fowles J, Dybing E. Application of toxicological risk assessment principles to the chemical constituents of cigarette smoke. Tob Control 2003; 12: 424–430.
169. Haussmann HJ. Use of hazard indices for a theoretical evaluation of cigarette smoke composition. Chem Res Toxicol 2012; 25: 794–810.
170. Goniewicz ML, Gawron M, Smith DM, et al. Exposure to nicotine and selected toxicants in cigarette smokers who switched to electronic cigarettes: a longitudinal within-subjects observational study. Nicotine Tob Res 2017; 19: 160–167.
171. McRobbie H, Phillips A, Goniewicz ML, et al. Effects of switching to electronic cigarettes with and without concurrent smoking on exposure to nicotine, carbon monoxide, and acrolein. Cancer Prev Res 2015; 8: 873–878.
172. Hecht SS, Carmella SG, Kotandeniya D, et al. Evaluation of toxicant and carcinogen metabolites in the urine of e-cigarette users versus cigarette smokers. Nicotine Tob Res 2015; 17: 704–709.
173. Shahab L, Goniewicz ML, Blount BC, et al. Nicotine, carcinogen, and toxin exposure in long-term e-cigarette and nicotine replacement therapy users: a cross-sectional study. Ann Intern Med 2017; 166: 390–400.
174. Messner B, Bernhard D. Smoking and cardiovascular disease: mechanisms of endothelial dysfunction and early atherogenesis. Arterioscler Thromb Vasc Biol 2014; 34: 509–515.
175. Csordas A, Bernhard D. The biology behind the atherothrombotic effects of cigarette smoke. Nat Rev Cardiol 2013; 10: 219–230.
176. Brook RD, Rajagopalan S, Pope CA, et al. Particulate matter air pollution and cardiovascular disease: an update to the scientific statement from the American Heart Association. Circulation 2010; 121: 2331–2378.
177. Williams M, Villarreal A, Bozhilov K, et al. Metal and silicate particles including nanoparticles are present in electronic cigarette cartomizer fluid and aerosol. PLoS One 2013; 8: e57987.
178. Hess CA, Olmedo P, Navas-Acien A, et al. E-cigarettes as a source of toxic and potentially carcinogenic metals. Environ Res 2017; 152: 221–225.
179. Farsalinos KE, Gillman G, Poulas K, et al. Tobacco-specific nitrosamines in electronic cigarettes: comparison between liquid and aerosol levels. Int J Environ Res Public Health 2015; 12: 9046–9053.
180. Allen JG, Flanigan SS, LeBlanc M, et al. Flavoring chemicals in e-cigarettes: diacetyl, 2,3-pentanedione, and acetoin in a sample of 51 products, including fruit-, candy-, and cocktail-flavored e-cigarettes. Environ Health Perspect 2016; 124: 733–739.
181. Fujioka K, Shibamoto T. Determination of toxic carbonyl compounds in cigarette smoke. Environ Toxicol 2006; 21: 47–54.
182. Chen IL. FDA summary of adverse events on electronic cigarettes. Nicotine Tob Res 2013; 15: 615–616.
183. Hom S, Chen L, Wang T, et al. Platelet activation, adhesion, inflammation, and aggregation potential are altered in the presence of electronic cigarette extracts of variable nicotine concentrations. Platelets 2016; 27: 694–702.
184. Polosa R, Morjaria J, Caponnetto P, et al. Effect of smoking abstinence and reduction in asthmatic smokers switching to electronic cigarettes: evidence for harm reversal. Int J Environ Res Public Health 2014; 11: 4965–4977.
185. Astrid Miler J, Mayer B. Changes in the frequency of airway infections in smokers who switched to vaping: results of an online survey. J Addict Res Ther 2016; 7: doi: 10.4172/2155-6105.1000290.
186. McConnell R, Barrington-Trimis JL, Wang K, et al. Electronic cigarette use and respiratory symptoms in adolescents. Am J Respir Crit Care Med 2017; 195: 1043–1049.
187. Monroy AE, Hommel E, Smith ST, et al. Paroxysmal atrial fibrillation following electronic cigarette use in an elderly woman. Clin Geriatr 2012; 20: 28–32.
188. Kim JW, Baum CR. Liquid nicotine toxicity. Pediatr Emerg Care 2015; 31: 517–521.
189. Vakkalanka JP, Hardison LS, Holstege CP. Epidemiological trends in electronic cigarette exposures reported to U.S. poison centers. Clin Toxicol 2014; 52: 542–548.
190. European Regulatory Science on Tobacco (EUREST) Consortium. Study on the Identification of Potential Risks to Public Health Associated with the use of Refillable Electronic Cigarettes and Development of Technical Specifications for Refill Mechanisms. 2016. https://ec.europa.eu/health/sites/health/files/tobacco/docs/potentialrisks_specs_refillableecigarettes.pdf
191. Jiwani AZ, Williams JF, Rizzo JA, et al. Thermal injury patterns associated with electronic cigarettes. Int J Burns Trauma 2017; 7: 1–5.
192. Fromme H, Schober W. Waterpipes and e-cigarettes: impact of alternative smoking techniques on indoor air quality and health. Atmos Environ 2015; 106: 429–441.
193. Czogala J, Goniewicz ML, Fidelus B, et al. Secondhand exposure to vapors from electronic cigarettes. Nicotine Tob Res 2014; 16: 655–662.
194. Geiss O, Bianchi I, Barahona F, et al. Characterisation of mainstream and passive vapours emitted by selected electronic cigarettes. Int J Hyg Environ Health 2015; 218: 169–180.
195. Schober W, Szendrei K, Matzen W, et al. Use of electronic cigarettes (e-cigarettes) impairs indoor air quality and increases FeNO levels of e-cigarette consumers. Int J Hyg Environ Health 2014; 217: 628–637.
196. Schripp T, Markewitz D, Uhde E, et al. Does e-cigarette consumption cause passive vaping? Indoor Air 2013; 23: 25–31.
197. Melstrom P, Koszowski B, Thanner MH, et al. Measuring PM2.5, ultrafine particles, air nicotine and wipe samples following the use of electronic cigarettes. Nicotine Tob Res 2017; 19: 1055–1061.
198. McAuley TR, Hopke PK, Zhao J, et al. Comparison of the effects of e-cigarette vapor and cigarette smoke on indoor air quality. Inhal Toxicol 2012; 24: 850–857.
199. Saffari A, Daher N, Ruprecht A, et al. Particulate metals and organic compounds from electronic and tobacco-containing cigarettes: comparison of emission rates and secondhand exposure. Environ Sci Process Impacts 2014; 16: 2259–2267.
200. Marco E, Grimalt JO. A rapid method for the chromatographic analysis of volatile organic compounds in exhaled breath of tobacco cigarette and electronic cigarette smokers. J Chromatogr A 2015; 1410: 51–59.
201. Soule EK, Maloney SF, Spindle TR, et al. Electronic cigarette use and indoor air quality in a natural setting. Tob Control 2017; 26: 109–112.
202. Klepeis NE, Bellettiere J, Hughes SC, et al. Fine particles in homes of predominantly low-income families with children and smokers: key physical and behavioral determinants to inform indoor-air-quality interventions. PLoS One 2017; 12: e0177718.
203. Gallart-Mateu D, Elbal L, Armenta S, et al. Passive exposure to nicotine from e-cigarettes. Talanta 2016; 152: 329–334.
204. Jarvis MJ, Russell MA, Feyerabend C, et al. Passive exposure to tobacco smoke: saliva cotinine concentrations in a representative population sample of non-smoking schoolchildren. Br Med J (Clin Res Ed) 1985; 291: 927–929.
205. Jarvis MJ, Feyerabend C, Bryant A, et al. Passive smoking in the home: plasma cotinine concentrations in non-smokers with smoking partners. Tob Control 2001; 10: 368–374.
206. St Helen G, Havel C, Dempsey DA, et al. Nicotine delivery, retention and pharmacokinetics from various electronic cigarettes. Addiction 2016; 111: 535–544.
207. Goniewicz ML, Lee L. Electronic cigarettes are a source of thirdhand exposure to nicotine. Nicotine Tob Res 2015; 17: 256–258.
208. Destaillats H, Singer BC, Lee SK, et al. Effect of ozone on nicotine desorption from model surfaces: evidence for heterogeneous chemistry. Environ Sci Technol 2006; 40: 1799–1805.
209. Polosa R, Caponnetto P, Morjaria JB, et al. Effect of an electronic nicotine delivery device (e-cigarette) on smoking reduction and cessation: a prospective 6-month pilot study. BMC Public Health 2011; 11: 786.
210. Caponnetto P, Campagna D, Cibella F, et al. EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PLoS One 2013; 8: e66317.
211. Bullen C, Howe C, Laugesen M, et al. Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet 2013; 382: 1629–1637.
212. Adriaens K, Van Gucht D, Declerck P, et al. Effectiveness of the electronic cigarette: an eight-week Flemish study with six-month follow-up on smoking reduction, craving and experienced benefits and complaints. Int J Environ Res Public Health 2014; 11: 11220–11248.
213. Hartmann-Boyce J, McRobbie H, Bullen C, et al. Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev 2016; 9: CD010216.
214. Stead LF, Perera R, Bullen C, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2012; 11: CD000146.
215. Pacifici R, Pichini S, Graziano S, et al. Successful nicotine intake in medical assisted use of e-cigarettes: a pilot study. Int J Environ Res Public Health 2015; 12: 7638–7646.
216. Polosa R, Caponnetto P, Maglia M, et al. Success rates with nicotine personal vaporizers: a prospective 6-month pilot study of smokers not intending to quit. BMC Public Health 2014; 14: 1159.
217. Polosa R, Caponnetto P, Cibella F, et al. Quit and smoking reduction rates in vape shop consumers: a prospective 12-month survey. Int J Environ Res Public Health 2015; 12: 3428–3438.
218. Hajek P, Corbin L, Ladmore D, et al. Adding e-cigarettes to specialist stop-smoking treatment: City of London pilot project. J Addict Res Ther 2015; 6: 244.
219. Caponnetto P, Auditore R, Russo C, et al. Impact of an electronic cigarette on smoking reduction and cessation in schizophrenic smokers: a prospective 12-month pilot study. Int J Environ Res Public Health 2013; 10: 446–461.
220. Halpern SD, Harhay MO, Saulsgiver K, et al. A pragmatic trial of e-cigarettes, incentives, and drugs for smoking cessation. N Engl J Med 2018; 378: 2302–2310.
221. Beard E, West R, Michie S, et al. Association between electronic cigarette use and changes in quit attempts, success of quit attempts, use of smoking cessation pharmacotherapy, and use of stop smoking services in England: time series analysis of population trends. BMJ 2016; 354: i4645.
222. West R, Shahab L, Brown J. Estimating the population impact of e-cigarettes on smoking cessation in England. Addiction 2016; 111: 1118–1119.
223. Action on Smoking and Health (ASH). Use of E-Cigarettes (Vapourisers) Among Adults in Great Britain. September 2018. http://ash.org.uk/download/use-of-e-cigarettes-among-adults-in-great-britain-2017
224. E-Cigarette Use Among Youth and Young Adults: A Report of the Surgeon General. Atlanta, U.S. Department of Health and Human Services, 2016.
225. Dautzenberg B, de Souza Moura M-A, Rieu N, et al. L’e-cigarette bouleverse les autres consommations des adolescents parisiens (2012 à 2014). [The e-cigarette disrupts other consumptions in Parisian teenagers (2012-2014)]. Rev Mal Respir 2016; 33: 225–234.
226. Lifestyles Statistics Team, Health and Social Care Information Centre. Statistics on Smoking: England 2015. Health and Social Care Information Centre, 2015.
227. Miech RA, Johnston LD, O’Malley PM, et al. Monitoring the Future National Survey Results on Drug Use, 1975–2015. Ann Arbor, Institute for Social Research, The University of Michigan, 2016.
228. Zhu SH, Zhuang YL, Wong S, et al. E-cigarette use and associated changes in population smoking cessation: evidence from US current population surveys. BMJ 2017; 358: j3262.
229. Brown J, Beard E, Kotz D, et al. Real-world effectiveness of e-cigarettes when used to aid smoking cessation: a cross-sectional population study. Addiction 2014; 109: 1531–1540.
230. NHS Digital. Statistics on NHS Stop Smoking Services: England, April 2015 to March 2016. https://files.digital.nhs.uk/publicationimport/pub21xxx/pub21162/stat-stop-smok-serv-eng-q4-1516-rep.pdf
231. Kalkhoran S, Glantz SA. E-cigarettes and smoking cessation in real-world and clinical settings: a systematic review and meta-analysis. Lancet Respir Med 2016; 4: 116–128.
232. Royal College of Physicians (RCP). Nicotine Without Smoke: Tobacco Harm Reduction. London, RCP, 2016.
233. Weaver SR, Huang J, Pechacek TF, et al. Are electronic nicotine delivery systems helping cigarette smokers quit? Evidence from a prospective cohort study of U.S. adult smokers, 2015-2016. PloS One 2018; 13: e0198047.
234. Maloney EK, Cappella JN. Does vaping in e-cigarette advertisements affect tobacco smoking urge, intentions, and perceptions in daily, intermittent, and former smokers? Health Commun 2016; 31: 129–138.
235. Barrington-Trimis JL, Berhane K, Unger JB, et al. The e-cigarette social environment, e-cigarette use, and susceptibility to cigarette smoking. J Adolesc Health 2016; 59: 75–80.
236. Rass O, Pacek LR, Johnson PS, et al. Characterizing use patterns and perceptions of relative harm in dual users of electronic and tobacco cigarettes. Exp Clin Psychopharmacol 2015; 23: 494–503.
237. Schmidt L, Reidmohr A, Harwell TS, et al. Prevalence and reasons for initiating use of electronic cigarettes among adults in Montana, 2013. Prev Chronic Dis 2014; 11: E204.
238. Harrell PT, Simmons VN, Piñeiro B, et al. E-cigarettes and expectancies: why do some users keep smoking? Addiction 2015; 110: 1833–1843.
239. Piñeiro B, Correa JB, Simmons VN, et al. Gender differences in use and expectancies of e-cigarettes: online survey results. Addict Behav 2016; 52: 91–97.
240. Gallus S, Lugo A, Pacifici R, et al. E-cigarette awareness, use, and harm perceptions in Italy: a national representative survey. Nicotine Tob Res 2014; 16: 1541–1548.
241. Brown-Johnson CG, Popova L. Exploring smoking stigma, alternative tobacco product use, & quit attempts. Health Behav Policy Rev 2016; 3: 13–20.
242. Pulvers K, Hayes RB, Scheuermann TS, et al. Tobacco use, quitting behavior, and health characteristics among current electronic cigarette users in a national tri-ethnic adult stable smoker sample. Nicotine Tob Res 2015; 17: 1085–1095.
243. Lechner WV, Tackett AP, Grant DM, et al. Effects of duration of electronic cigarette use. Nicotine Tob Res 2015; 17: 180–185.
244. Hitchman SC, Brose LS, Brown J, et al. Associations between e-cigarette type, frequency of use, and quitting smoking: findings from a longitudinal online panel survey in Great Britain. Nicotine Tob Res 2015; 17: 1187–1194.
245. Biener L, Hargraves JL. A longitudinal study of electronic cigarette use among a population-based sample of adult smokers: association with smoking cessation and motivation to quit. Nicotine Tob Res 2015; 17: 127–133.
246. Grace RC, Kivell BM, Laugesen M. Estimating cross-price elasticity of e-cigarettes using a simulated demand procedure. Nicotine Tob Res 2015; 17: 592–598.
247. Farsalinos KE, Romagna G, Voudris V. Factors associated with dual use of tobacco and electronic cigarettes: a case control study. Int J Drug Policy 2015; 26: 595–600.
248. Sutfin EL, McCoy TP, Morrell HE, et al. Electronic cigarette use by college students. Drug Alcohol Depend 2013; 131: 214–221.
249. Saddleson ML, Kozlowski LT, Giovino GA, et al. Enjoyment and other reasons for electronic cigarette use: results from college students in New York. Addict Behav 2016; 54: 33–39.
250. Soneji S, Sargent J, Tanski S. Multiple tobacco product use among US adolescents and young adults. Tob Control 2016; 25: 174–180.
251. Cooper M, Case KR, Loukas A, et al. E-cigarette dual users, exclusive users and perceptions of tobacco products. Am J Health Behav 2016; 40: 108–116.
252. Goniewicz ML, Leigh NJ, Gawron M, et al. Dual use of electronic and tobacco cigarettes among adolescents: a cross-sectional study in Poland. Int J Public Health 2016; 61: 189–197.
253. Rüther T, Wissen F, Linhardt A, et al. Electronic cigarettes – attitudes and use in Germany. Nicotine Tob Res 2016; 18: 660–669.
254. Coleman BN, Apelberg BJ, Ambrose BK, et al. Association between electronic cigarette use and openness to cigarette smoking among US young adults. Nicotine Tob Res 2015; 17: 212–218.
255. Moore GF, Littlecott HJ, Moore L, et al. E-cigarette use and intentions to smoke among 10-11-year-old never-smokers in Wales. Tob Control 2016; 25: 147–152.
256. Primack BA, Soneji S, Stoolmiller M, et al. Progression to traditional cigarette smoking after electronic cigarette use among US adolescents and young adults. JAMA Pediatr 2015; 169: 1018–1023.
257. Wills TA, Sargent JD, Knight R, et al. E-cigarette use and willingness to smoke: a sample of adolescent non-smokers. Tob Control 2016; 25: e52–e59.
258. Best C, Haseen F, Currie D, et al. Relationship between trying an electronic cigarette and subsequent cigarette experimentation in Scottish adolescents: a cohort study. Tob Control 2017; doi: 10.1136/tobaccocontrol-2017-053691.
259. Trumbo CW, Harper R. Use and perception of electronic cigarettes among college students. J Am Coll Health 2013; 61: 149–155.
260. Best C, van der Sluijs W, Haseen F, et al. Does exposure to cigarette brands increase the likelihood of adolescent e-cigarette use? A cross-sectional study. BMJ Open 2016; 6: e008734.
261. Cardenas VM, Evans VL, Balamurugan A, et al. Use of electronic nicotine delivery systems and recent initiation of smoking among US youth. Int J Public Health 2016; 61: 237–241.
262. Hughes K, Bellis MA, Hardcastle KA, et al. Associations between e-cigarette access and smoking and drinking behaviours in teenagers. BMC Public Health 2015; 15: 244.
263. Kinnunen JM, Ollila H, El-Tayeb El-Amin S, et al. Awareness and determinants of electronic cigarette use among Finnish adolescents in 2013: a population-based study. Tob Control 2015; 24: e264–e270.
264. Lessard J, Henrie J, Livingston JA, et al. Correlates of ever having used electronic cigarettes among older adolescent children of alcoholic fathers. Nicotine Tob Res 2014; 16: 1656–1660.
265. Saddleson ML, Kozlowski LT, Giovino GA, et al. Risky behaviors, e-cigarette use and susceptibility of use among college students. Drug Alcohol Depend 2015; 149: 25–30.
266. Stenger N, Chailleux E. Enquête sur l’usage de la cigarette électronique et du tabac en milieu scolaire. [Survey on the use of electronic cigarettes and tobacco among children in middle and high school]. Rev Mal Respir 2015; 33: 56–62.
267. Meier EM, Tackett AP, Miller MB, et al. Which nicotine products are gateways to regular use? First-tried tobacco and current use in college students. Am J Prev Med 2015; 48: S86–S93.
268. Sutfin EL, Reboussin BA, Debinski B, et al. The impact of trying electronic cigarettes on cigarette smoking by college students: a prospective analysis. Am J Public Health 2015; 105: e83–e89.
269. Leventhal AM, Strong DR, Kirkpatrick MG, et al. Association of electronic cigarette use with initiation of combustible tobacco product smoking in early adolescence. JAMA 2015; 314: 700–707.
270. Barrington-Trimis JL, Urman R, Berhane K, et al. E-cigarettes and future cigarette use. Pediatrics 2016; 138: e20160379.
271. Soneji S, Barrington-Trimis JL, Wills TA, et al. Association between initial use of e-cigarettes and subsequent cigarette smoking among adolescents and young adults: a systematic review and meta-analysis. JAMA Pediatr 2017; 171: 788–797.
272. Zhong J, Cao S, Gong W, et al. Electronic cigarettes use and intention to cigarette smoking among never-smoking adolescents and young adults: a meta-analysis. Int J Environ Res Public Health 2016; 13: E465.
273. Etter JF. Gateway effects and electronic cigarettes. Addiction 2018; 113: 1776–1783.
274. Kristjansson AL, Mann MJ, Sigfusdottir ID. Licit and illicit substance use by adolescent e-cigarette users compared with conventional cigarette smokers, dual users, and nonusers. J Adolesc Health 2015; 57: 562–564.
275. Hampson SE, Andrews JA, Severson HH, et al. Prospective predictors of novel tobacco and nicotine product use in emerging adulthood. J Adolesc Health 2015; 57: 186–191.
276. Pentz MA, Shin H, Riggs N, et al. Parent, peer, and executive function relationships to early adolescent e-cigarette use: a substance use pathway? Addict Behav 2015; 42: 73–78.
277. Biener L, Song E, Sutfin EL, et al. Electronic cigarette trial and use among young adults: reasons for trial and cessation of vaping. Int J Environ Res Public Health 2015; 12: 16019–16026.
278. Coleman BN, Johnson SE, Tessman GK, et al. “It’s not smoke. It’s not tar. It’s not 4000 chemicals. Case closed”: exploring attitudes, beliefs, and perceived social norms of e-cigarette use among adult users. Drug Alcohol Depend 2016; 159: 80–85.
279. Farsalinos KE, Romagna G, Tsiapras D, et al. Characteristics, perceived side effects and benefits of electronic cigarette use: a worldwide survey of more than 19,000 consumers. Int J Environ Res Public Health 2014; 11: 4356–4373.
280. Harrell PT, Marquinez NS, Correa JB, et al. Expectancies for cigarettes, e-cigarettes, and nicotine replacement therapies among e-cigarette users (aka vapers). Nicotine Tob Res 2015; 17: 193–200.
281. Hendricks PS, Cases MG, Thorne CB, et al. Hospitalized smokers’ expectancies for electronic cigarettes versus tobacco cigarettes. Addict Behav 2015; 41: 106–111.
282. Farsalinos KE, Romagna G, Tsiapras D, et al. Impact of flavour variability on electronic cigarette use experience: an internet survey. Int J Environ Res Public Health 2013; 10: 7272–7282.
283. Goniewicz ML, Lingas EO, Hajek P. Patterns of electronic cigarette use and user beliefs about their safety and benefits: an internet survey. Drug Alcohol Rev 2013; 32: 133–140.
284. McDonald EA, Ling PM. One of several “toys” for smoking: young adult experiences with electronic cigarettes in New York City. Tob Control 2015; 24: 588–593.
285. Pokhrel P, Herzog TA, Muranaka N, et al. Young adult e-cigarette users’ reasons for liking and not liking e-cigarettes: a qualitative study. Psychol Health 2015; 30: 1450–1469.
286. Rooke C, Cunningham-Burley S, Amos A. Smokers’ and ex-smokers’ understanding of electronic cigarettes: a qualitative study. Tob Control 2016; 25: e60–e66.
287. Etter J-F. Electronic cigarettes: a survey of users. BMC Public Health 2010; 10: 231.
288. Nădăşan V, Foley KL, Pénzes M, et al. Use of electronic cigarettes and alternative tobacco products among Romanian adolescents. Int J Public Health 2016; 61: 199–207.
289. Filippidis FT, Laverty AA, Gerovasili V, et al. Two-year trends and predictors of e-cigarette use in 27 European Union member states. Tob Control 2017; 26: 98–104.
290. Berg CJ. Preferred flavors and reasons for e-cigarette use and discontinued use among never, current, and former smokers. Int J Public Health 2016; 61: 225–236.
291. Gaga M, Welte T, Troosters T, et al. Rapid response: Electronic cigarettes for smoking cessation. BMJ 2018; 360: j5543.